1. Generics Bulletin
  2. >>Products
  3. >>Generics

MPP Announces Generic Paxlovid Licences For LMICs

Generics Of Pfizer’s Oral COVID-19 Treatment Will Be Supplied To 95 Countries

 
• By Chloe Kent

A group of 35 generics manufacturers have signed agreements with the Medicines Patent Pool to supply Paxlovid generics to 95 low- and middle-income countries.

Paxlovid bottle
Paxlovid is an antiviral for the treatment of mild-to-moderate COVID-19 in high-risk patients • Source: Alamy

A total of 35 global generics manufacturers have signed agreements with the Medicines Patent Pool to supply generic versions of Pfizer’s COVID-19 antiviral treatment Paxlovid (nirmatrelvir and low-dose ritonavir tablets, co-packaged for oral use), which will then be supplied to 95 low- and middle-income countries. The drug is intended to be used as a treatment for early-stage, mild-to-moderate COVID-19 in adults and pediatric patients aged 12 and over who are at high risk of progressing to more serious illness.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Generics

More from Products